Reported Earnings • Nov 19
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: zł3.47m (up 308% from 3Q 2024). Net loss: zł1.41m (loss narrowed 36% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. 공시 • Nov 13
Cosma S.A. to Report Q3, 2025 Results on Nov 14, 2025 Cosma S.A. announced that they will report Q3, 2025 results on Nov 14, 2025 New Risk • Jun 08
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł4.9m free cash flow). Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 80% per year over the past 5 years. Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Minor Risks Revenue is less than US$5m (zł7.5m revenue, or US$2.0m). Market cap is less than US$100m (zł66.0m market cap, or US$17.5m). Reported Earnings • Feb 17
Full year 2024 earnings released Full year 2024 results: Revenue: zł7.46m (up 186% from FY 2023). Net loss: zł9.24m (loss narrowed 37% from FY 2023). New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł6.0m free cash flow). Earnings have declined by 91% per year over the past 5 years. Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Revenue is less than US$1m (zł4.0m revenue, or US$953k). Minor Risks Share price has been volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$100m (zł80.1m market cap, or US$19.3m). 공시 • Jun 05
Cosma S.A., Annual General Meeting, Jun 28, 2024 Cosma S.A., Annual General Meeting, Jun 28, 2024. New Risk • Mar 28
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: zł36.1m (US$9.03m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł5.5m free cash flow). Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 90% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 21x increase in shares outstanding). Revenue is less than US$1m (zł2.6m revenue, or US$653k). Market cap is less than US$10m (zł36.1m market cap, or US$9.03m). New Risk • Feb 20
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł5.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł5.5m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 90% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 21x increase in shares outstanding). Revenue is less than US$1m (zł2.6m revenue, or US$650k). Minor Risk Market cap is less than US$100m (zł52.9m market cap, or US$13.2m). New Risk • Feb 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 63% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 21x increase in shares outstanding). Revenue is less than US$1m (zł1.6m revenue, or US$407k). Minor Risk Market cap is less than US$100m (zł60.1m market cap, or US$15.0m). New Risk • Jul 04
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: zł37.8m (US$9.31m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł173k free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 39% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (zł37.8m market cap, or US$9.31m). 공시 • Jun 04
Cosma Group S.A., Annual General Meeting, Jun 29, 2023 Cosma Group S.A., Annual General Meeting, Jun 29, 2023, at 09:00 Central European Standard Time. 공시 • Apr 21
Cosma Group S.A., Annual General Meeting, May 17, 2022 Cosma Group S.A., Annual General Meeting, May 17, 2022. Reported Earnings • Aug 21
Second quarter 2021 earnings released The company reported a soft second quarter result with weaker revenues and control over costs, although losses reduced. Second quarter 2021 results: Revenue: zł750 (down 100% from 2Q 2020). Net loss: zł65.3k (loss narrowed 44% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 17
Full year 2020 earnings released: EPS zł0.005 (vs zł0.069 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: zł584.8k (down 70% from FY 2019). Net income: zł24.6k (down 93% from FY 2019). Profit margin: 4.2% (down from 17% in FY 2019). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment improved over the past week After last week's 20% share price gain to zł3.60, the stock is trading at a trailing P/E ratio of 45x, up from the previous P/E ratio of 37.5x. This compares to an average P/E of 21x in the Personal Products industry in Poland. Total returns to shareholders over the past year are 288%. Valuation Update With 7 Day Price Move • Jan 18
Investor sentiment improved over the past week After last week's 17% share price gain to zł3.85, the stock is trading at a trailing P/E ratio of 48.2x, up from the previous P/E ratio of 41.3x. This compares to an average P/E of 22x in the Personal Products industry in Poland. Total returns to shareholders over the past year are 267%. Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improved over the past week After last week's 17% share price gain to zł3.28, the stock is trading at a trailing P/E ratio of 41x, up from the previous P/E ratio of 35x. This compares to an average P/E of 21x in the Personal Products industry in Poland. Total returns to shareholders over the past year are 256%. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment deteriorated over the past week After last week's 17% share price decline to zł3.35, the stock is trading at a trailing P/E ratio of 41.9x, down from the previous P/E ratio of 50.6x. This compares to an average P/E of 20x in the Personal Products industry in Poland. Total returns to shareholders over the past year are 264%. Is New 90 Day High Low • Dec 28
New 90-day high: zł4.04 The company is up 269% from its price of zł1.10 on 29 September 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 27% over the same period. Is New 90 Day High Low • Dec 08
New 90-day high: zł1.43 The company is up 43% from its price of zł1.00 on 09 September 2020. The Polish market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 3.0% over the same period. Valuation Update With 7 Day Price Move • Dec 08
Market bids up stock over the past week After last week's 36% share price gain to zł1.43, the stock is trading at a trailing P/E ratio of 17.9x, up from the previous P/E ratio of 13.1x. This compares to an average P/E of 15x in the Personal Products industry in Poland. Total returns to shareholders over the past year are 53%. Valuation Update With 7 Day Price Move • Nov 25
Market bids up stock over the past week After last week's 18% share price gain to zł1.07, the stock is trading at a trailing P/E ratio of 13.3x, up from the previous P/E ratio of 11.3x. This compares to an average P/E of 14x in the Personal Products industry in Poland. Total returns to shareholders over the past year are 15%. Is New 90 Day High Low • Oct 29
New 90-day low: zł0.91 The company is down 47% from its price of zł1.73 on 30 July 2020. The Polish market is down 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 27% over the same period.